|Articles|January 1, 2002

PDT may aid patients with minimally classic CNV

Study of verteporfin therapy leads to new VIM Trial to determine effectof fluence rate, light dose

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME